Previous studies have shown that high expression of Nrf2 target genes, including NQO1 [20], GPX2 [21], and TXNRD1 [22], is strongly associated with poor prognosis in HCC patients. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.